The INTACT trial is a multisite pilot feasibility study aimed at testing the effectiveness of the INTACT Intervention program in improving neurodevelopmental outcomes in infants prenatally exposed to cannabinoids. The trial will enroll 20 birthing parent/infant dyads across three sites and will evaluate feasibility endpoints rather than clinical outcomes. The study duration is 22 months, including study start-up, enrollment and intervention, and data analysis and manuscript preparation.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Percentage of approached participants that are eligible for study participation
Timeframe: 3 months
Percentage of participants that complete their final visit
Timeframe: 12 months following enrollment
Percentage of participants that receive a sufficient number of coaching sessions
Timeframe: 12 months following enrollment